Highlights
NASDAQ: CYAD       Celyad Sa Ads
Last Price Today's Change   Day's Range   Trading Volume
10.88   +0.02 (0.18%)  10.53 - 11.19  94,227

Overview

 
Avg Volume (4 weeks):65,142
4 Weeks Range:8.60 - 12.937
4 Weeks Price Volatility (%):
52.57%
52 Weeks Range:8.10 - 25.36
52 Weeks Price Volatility (%):
16.11%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Celyad SA is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Corporate operating segments. It derives majority of its revenues from Cardiology segment.

  Be the first to like this.
 


 

3637  2095  320  2919 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 BAC 34.68+1.04 
 CHK 0.783+0.038 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 F 9.32+0.21 
 AABA 19.630.00 
Partners & Brokers